Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I
about
Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesisRibozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts.Perlecan domain IV peptide stimulates salivary gland cell assembly in vitroDynamic expression patterns of ECM molecules in the developing mouse olfactory pathwayHeparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formationPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.WARP is a novel multimeric component of the chondrocyte pericellular matrix that interacts with perlecanPerlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro.Progranulin: a promising therapeutic target for rheumatoid arthritis.Effects of culture on PAMPS/PDMAAm double-network gel on chondrogenic differentiation of mouse C3H10T1/2 cells: in vitro experimental study.Perlecan and tumor angiogenesis.Progranulin: a growth factor, a novel TNFR ligand and a drug targetMultilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release.Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue bordersCurrent advances in the development of natural meniscus scaffolds: innovative approaches to decellularization and recellularization.Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices.Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan.Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis.Potential of exogenous cartilage proteoglycan as a new material for cartilage regeneration.Perlecan: an important component of the cartilage pericellular matrix.Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.
P2860
Q24295251-10791D95-BC00-4666-9E38-69632D3987A9Q24540423-FA72D2C4-4D6B-49C1-A677-D23E2271A719Q24642832-F1F05901-958B-402E-AA67-B364CEC222DDQ24647080-77DF58EF-67B0-41F7-B38C-3A7B509A9F82Q24650523-F9041ED7-76C0-41E7-8E3D-489E82DD28D9Q24653433-142E5B68-7519-4ED7-BA05-FFEA46D21831Q28512220-CCB455B6-0AAC-43DE-9A1E-251EB15A52D3Q34419440-2957793B-CC3A-4C4D-AA2A-B1FA4E9977D0Q35182029-31CF34A1-11AD-4378-B6A7-00119B70689DQ35281711-B5A33F27-4E15-470E-B559-CA61F01D58CDQ35562693-AB8787E3-DCF8-4EE0-B6E1-BFEE337B02DEQ35601050-EF42BD56-C8EE-45C8-871B-841FF2BD7801Q35985227-62D26F36-4E39-44D0-BD76-EED25D77B4C7Q37117272-1D781925-E982-4D32-85AC-510D751ED82CQ37441477-6390B9A7-EFDD-43B3-B34B-CC988783E3D4Q37610826-566BB01A-261E-41FA-A143-F321AED33C39Q38736894-FE4240FA-2F8E-4EE5-871F-EE54B541BE3DQ39078431-7533B4D4-C4E1-4AFC-B287-E78239644BE7Q40053261-1ECAA3F0-6633-44D1-88AE-100D4820709DQ40247376-6846B572-6DBB-46A6-867C-0D2106EC4233Q40380295-F5D94738-5639-42C1-AB98-27D43004E1BAQ42184028-C2368311-9C9D-45EE-AF3A-8689F998CB5CQ42568509-D4D5A05C-A485-4AD3-B748-EAF387B5B7E5Q43229719-45BB53E7-D9DF-4252-8859-3004B35597FBQ53604003-8A640ABD-C0DD-44B4-B364-AE647F56EB41
P2860
Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@ast
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@en
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@nl
type
label
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@ast
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@en
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@nl
prefLabel
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@ast
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@en
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@nl
P2093
P2860
P1476
Chondrogenic activity of the h ...... aps to the N-terminal domain I
@en
P2093
Daniel D Carson
Kirk Czymmek
Margaret M French
Mary C Farach-Carson
Ronald R Gomes
Rupert Timpl
P2860
P356
10.1359/JBMR.2002.17.1.48
P407
P50
P577
2002-01-01T00:00:00Z